Education
About Us
Working with TipRanks
Follow Us
Mind Medicine (MNMD)
NASDAQ:MNMD
Total Valuation
Mind Medicine has a market cap or net worth of $588.56M. The enterprise value is -$74.18M.
Market Cap$588.56M
Enterprise Value-$74.18M
Share Statistics
Mind Medicine has 75,553,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,553,270
Owned by Insiders2.75%
Owned by Institutions48.98%
Financial Efficiency
Mind Medicine’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -39.47%.
Return on Equity (ROE)-0.45
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-39.47%
Return on Capital Employed (ROCE)-0.39
Revenue Per Employee0.00
Profits Per Employee-1.91M
Employee Count57
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mind Medicine is -4.51. Mind Medicine’s PEG ratio is 0.03.
PE Ratio-4.51
PS Ratio0.00
PB Ratio0.45
Price to Fair Value2.03
Price to FCF-1.35
Price to Operating Cash Flow-1.35
PEG Ratio0.03
Income Statement
In the last 12 months, Mind Medicine had revenue of 0.00 and earned -108.68M in profits. Earnings per share was -1.54.
Revenue0.00
Gross Profit0.00
Operating Income-103.92M
Pretax Income-108.68M
Net Income-108.68M
EBITDA-103.92M
Earnings Per Share (EPS)-1.54
Cash Flow
In the last 12 months, operating cash flow was -91.69M and capital expenditures 0.00, giving a free cash flow of -71.96M billion.
Operating Cash Flow-91.69M
Free Cash Flow-71.96M
Free Cash Flow per Share-0.95
Dividends & Yields
Mind Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change3.05%
50-Day Moving Average6.43
200-Day Moving Average6.74
Relative Strength Index (RSI)65.26
Average Volume (3m)1.09M
Important Dates
Mind Medicine upcoming earnings date is Aug 14, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend Date―
Financial Position
Mind Medicine as a current ratio of 7.25, with Debt / Equity ratio of 0.05%
Current Ratio7.25
Quick Ratio7.25
Debt to Market Cap0.04
Net Debt to EBITDA2.42
Interest Coverage Ratio-45.52
Taxes
In the past 12 months, Mind Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Mind Medicine EV to EBITDA ratio is -2.30, with an EV/FCF ratio of -3.01.
EV to Sales0.00
EV to EBITDA-2.30
EV to Free Cash Flow-3.01
EV to Operating Cash Flow-3.01
Balance Sheet
Mind Medicine has $212.44M in cash and marketable securities with $22.04M in debt, giving a net cash position of -$190.41M billion.
Cash & Marketable Securities$212.44M
Total Debt$22.04M
Net Cash-$190.41M
Net Cash Per Share-$2.52
Tangible Book Value Per Share$3.14
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mind Medicine is $23.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$23.22
Price Target Upside268.57% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast26.24%